Delivery Order SPE2DR25D2100-SPE2DR26FA0JA
Award Date 12/1/25
Potential Completion Date 12/2/25
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain for $3,357.82 on September 5, 2025, with an ultimate completion date of September 8, 2025. The contract covers the supply of Quillivant XR 25 mg/5 ml suspension (120 ml), an extended-release liquid formulation of methylphenidate used to treat attention deficit hyperactivity disorder. This is a firm fixed-price delivery order with no set-aside designation, issued as a child contract...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,347.48 by the Defense Logistics Agency's Medical Supply Chain on September 2, 2025, for the supply of Quillivant 25mg/5ml (methylphenidate extended-release suspension), a pharmaceutical product used in the treatment of attention-deficit/hyperactivity disorder. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of September 29, 2025. The place of...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Quillivant XR oral suspension (60mL, 5mg/mL), a medication used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order has a ceiling value of $8,284.62 and is scheduled for completion by October 28, 2025. The contract was placed with AmerisourceBergen's Corporate Office location in Conshohocken,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency (DLA) on June 18, 2025, valued at $1,597.18 for the supply of Quillivant XR 25 mg/5 ml suspension (180 ml). The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 20, 2025. Performance will occur at the vendor's corporate office location in Conshohocken, PA. This delivery order represents a child...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Quillivant XR Oral Suspension 60ML 5MG/ML, a pharmaceutical product used in the treatment of attention deficit disorders. The award, valued at $9,205.46, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,346.53 by the Defense Logistics Agency on July 14, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in a 150 ml quantity. The contract utilizes firm fixed price pricing and is not designated as a set-aside award, indicating it was competitively procured. This delivery order represents a child contract issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency for Quillivant XR 25 mg/5 ml suspension (60 ml), valued at $2,361.84, with an ultimate completion date of November 5, 2025. This is a firm fixed price, non-set-aside contract representing a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX). The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,534.24 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension (60 mL), a methylphenidate-based medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, with an ultimate completion date of December 4, 2025, was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency valued at $1,736.54 for Quillivant XR 25 mg/5 mL suspension (120 mL), a medication commonly prescribed for attention-deficit/hyperactivity disorder. The contract is not set-aside, indicating it was awarded through open competition. The delivery order carries a firm fixed price structure with an ultimate completion date of December 5, 2025, and will be performed at AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $3,494.96 to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 ml suspension (150 ml), a pharmaceutical product used in attention-deficit/hyperactivity disorder treatment. This competitively awarded, firm fixed-price delivery order was issued on December 2, 2025, with an ultimate completion date of December 3, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...